Search - tctmd.com

Displaying 41 - 60 of 129

Sort: Relevancy | Date

News Daily News

Many CVD Risk Factors Remain Uncontrolled in Men and Women, but Emphasis Differs

Lucy Hicks

February 21, 2019

News Daily News

SURTAVI Stroke Analysis Published, Confirms Less Early Stroke With TAVR

Todd Neale

October 22, 2018

Presentation TCT 2018

Keystone TRIGUARD Cerebral Embolic Protection During TAVR: New Generation Devices and the Status of Ongoing Clinical Trials

Presenter: Alexandra J. Lansky, Axel Linke, Tamim Nazif

September 22, 2018

Presentation TCT 2018

A Stroke after TAVR Primer: Time Course, Changing Incidence, Ascertainment Challenges, and Comparison vs. Surgery

Presenter: Alexandra J. Lansky, Axel Linke, Samir R. Kapadia

September 22, 2018

Presentation TCT 2018

TCT-72: A Prospective Evaluation for Hypoattenuated Leaflet Thickening Following Transcatheter Aortic Valve Replacement

Presenter: Alex Chebl, Alexandra J. Lansky, Liang Tang

September 21, 2018

Presentation TCT 2018

TCT-71: Predictors, Incidence and Outcomes of Patients Undergoing Transcatheter Aortic Valve Implantation Complicated by Stroke From the CENTER-Collaboration

Presenter: Alex Chebl, Alexandra J. Lansky, Wieneke Vlastra

September 21, 2018

Presentation TCT 2018

TCT-70: Incidence, Trends, and Risk Factors for Early Stroke after Transcatheter Aortic Valve Replacement in the First 5 years of US Clinical Practice: Report of the STS/ACC TVT Registry.

Presenter: Alex Chebl, Alexandra J. Lansky, Chetan Huded

September 21, 2018

Presentation TCT 2018

TCT-69: Transcatheter Aortic Heart Valves: Histological Analysis Providing Insight to Leaflet Thickening and Structural Valve Degeneration

Presenter: Alex Chebl, Alexandra J. Lansky, Stephanie Sellars

September 21, 2018

News Conference News The Structural Heart Disease Summit 2018

Data or Money: What’s Holding Back Cerebral Embolic Protection in TAVR?

Shelley Wood

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Strokes After TAVR (and SAVR): Incidence in the "Modern Era" and Key Messages From NeuroARC

Presenter: Eberhard Grube, Tamim Nazif, Alexandra J. Lansky

June 21, 2018

News Conference News TCT 2017

Quantitative Flow Ratio Shows Potential in Cath Lab

TCT Daily Staff

November 03, 2017

Presentation TCT 2017

When to Use Cerebral Protection During TAVR

Presenter: Alfredo Trento, Alexandra J. Lansky

November 01, 2017

Presentation TCT 2017

The Compelling Saga of Stroke after TAVR: Key Messages From NeuroARC

Presenter: Michael J. Reardon, Didier Tchetche, Alexandra J. Lansky

October 31, 2017

News Conference News PCR London Valves 2017

Valve Deterioration and Durability Definitions Now Standardized in New Guide

Shelley Wood

September 25, 2017

Manuscript

Cerebral Embolic Protection: Point–Counter Point

September 08, 2017

News Industry News

TriReme Medical Reports Negative Late Lumen Loss At 24-Month Angiographic Follow-Up For Chocolate Heart™ Drug-Coated Coronary Balloon

June 22, 2017

News Conference News TVT 2017

Embolic Protection During TAVR Reduces Stroke Risk, Single-Center Study Shows

Michael O'Riordan

June 15, 2017

Presentation TVT 2017

A Randomized Trial of Cerebral Embolic Protection in Patients Undergoing Surgical Aortic Valve Replacement (SAVR)

Presenter: Alexandra J. Lansky, Nicolas M. Van Mieghem, Michael J. Mack

June 15, 2017

Presentation TVT 2017

The Compelling Saga of Strokes After TAVR (and SAVR): Diagnosis Considerations and Key Messages From NeuroARC

Presenter: Alexandra J. Lansky, Nicolas M. Van Mieghem

June 15, 2017

News Daily News

NeuroARC Proposes New Standards for Assessing Neurologic Damage in CV Clinical Trials

Caitlin E. Cox

February 07, 2017

Advertisement

Many CVD Risk Factors Remain Uncontrolled in Men and Women, but Emphasis Differs

SURTAVI Stroke Analysis Published, Confirms Less Early Stroke With TAVR

Keystone TRIGUARD Cerebral Embolic Protection During TAVR: New Generation Devices and the Status of Ongoing Clinical Trials

A Stroke after TAVR Primer: Time Course, Changing Incidence, Ascertainment Challenges, and Comparison vs. Surgery

TCT-72: A Prospective Evaluation for Hypoattenuated Leaflet Thickening Following Transcatheter Aortic Valve Replacement

TCT-71: Predictors, Incidence and Outcomes of Patients Undergoing Transcatheter Aortic Valve Implantation Complicated by Stroke From the CENTER-Collaboration

TCT-70: Incidence, Trends, and Risk Factors for Early Stroke after Transcatheter Aortic Valve Replacement in the First 5 years of US Clinical Practice: Report of the STS/ACC TVT Registry.

TCT-69: Transcatheter Aortic Heart Valves: Histological Analysis Providing Insight to Leaflet Thickening and Structural Valve Degeneration

Data or Money: What’s Holding Back Cerebral Embolic Protection in TAVR?

Strokes After TAVR (and SAVR): Incidence in the "Modern Era" and Key Messages From NeuroARC

Quantitative Flow Ratio Shows Potential in Cath Lab

When to Use Cerebral Protection During TAVR

The Compelling Saga of Stroke after TAVR: Key Messages From NeuroARC

Valve Deterioration and Durability Definitions Now Standardized in New Guide

Cerebral Embolic Protection: Point–Counter Point

TriReme Medical Reports Negative Late Lumen Loss At 24-Month Angiographic Follow-Up For Chocolate Heart™ Drug-Coated Coronary Balloon

Embolic Protection During TAVR Reduces Stroke Risk, Single-Center Study Shows

A Randomized Trial of Cerebral Embolic Protection in Patients Undergoing Surgical Aortic Valve Replacement (SAVR)

The Compelling Saga of Strokes After TAVR (and SAVR): Diagnosis Considerations and Key Messages From NeuroARC

NeuroARC Proposes New Standards for Assessing Neurologic Damage in CV Clinical Trials

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content